Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Sponsor
Alliance for Clinical Trials in Oncology (Other)
Overall Status
Completed
CT.gov ID
NCT00043069
Collaborator
National Cancer Institute (NCI) (NIH)
71
114
4
86
0.6
0

Study Details

Study Description

Brief Summary

RATIONALE: Preventing bone loss in patients who are undergoing androgen ablation for prostate cancer may decrease the risk of fractures and may help patients live more comfortably. It is not yet known whether calcium is more effective with or without estrogen and/or risedronate in preventing osteoporosis.

PURPOSE: Randomized phase III trial to compare the effectiveness of two forms of calcium with or without estrogen and/or risedronate in preventing osteoporosis in patients with prostate cancer who are receiving androgen ablation therapy.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: calcium carbonate
  • Dietary Supplement: cholecalciferol
  • Drug: Estrogen Antagonists
  • Drug: risedronate sodium
  • Other: placebo
Phase 3

Detailed Description

OBJECTIVES:
  • Compare the change in bone mineral density in patients with prostate cancer who are receiving androgen-ablation therapy treated with calcium and cholecalciferol with or without conjugated estrogens and with or without risedronate.

  • Compare the toxicity of these regimens in these patients.

  • Compare the changes in bone markers in patients treated with these regimens.

  • Compare the quality of life of patients treated with these regimens.

  • Compare hot flashes in patients treated with these regimens.

OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to duration of therapy with luteinizing hormone-releasing hormone agonists (no more than 30 days vs 31 to 150 days vs 151 to 365 days vs more than 365 days). Patients are randomized to 1 of 4 treatment arms.

  • Arm I: Patients receive oral calcium, oral cholecalciferol, oral risedronate placebo, and oral estrogen placebo daily.

  • Arm II: Patients receive oral calcium, oral cholecalciferol, oral risedronate, and oral estrogen placebo daily.

  • Arm III: Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate placebo daily.

  • Arm IV: Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate daily.

Treatment in all arms continues for 2 years.

Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years.

Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years.

PROJECTED ACCRUAL: A total of 282 patients (70 per treatment arm) will be accrued for this study within 14 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
71 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Study Start Date :
Nov 1, 2002
Actual Primary Completion Date :
Jun 1, 2006
Actual Study Completion Date :
Jan 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm I: calcium + cholecalciferol + placebo + estrogen

Patients receive oral calcium, oral cholecalciferol, oral risedronate placebo, and oral estrogen placebo daily. Treatment in all arms continues for 2 years. Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years. Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years.

Dietary Supplement: calcium carbonate

Dietary Supplement: cholecalciferol

Drug: Estrogen Antagonists

Other: placebo

Experimental: Arm II: calcium + cholecalciferol + risedronate + estrogen

Patients receive oral calcium, oral cholecalciferol, oral risedronate, and oral estrogen placebo daily. Treatment in all arms continues for 2 years. Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years. Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years.

Dietary Supplement: calcium carbonate

Dietary Supplement: cholecalciferol

Drug: Estrogen Antagonists

Drug: risedronate sodium

Placebo Comparator: Arm III: calcium + cholecalciferol + placebo + estrogen

Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate placebo daily. Treatment in all arms continues for 2 years. Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years. Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years.

Dietary Supplement: calcium carbonate

Dietary Supplement: cholecalciferol

Drug: Estrogen Antagonists

Other: placebo

Experimental: Arm IV: calcium + cholecalciferol + risedronate + estrogen

Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate daily. Treatment in all arms continues for 2 years. Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years. Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years.

Dietary Supplement: calcium carbonate

Dietary Supplement: cholecalciferol

Drug: Estrogen Antagonists

Drug: risedronate sodium

Outcome Measures

Primary Outcome Measures

  1. Bone mineral density by test at 1 and 2 years [Up to 2 years]

Secondary Outcome Measures

  1. Toxicity questionnaires every 6 months [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • History of prostate cancer

  • No evidence of metastatic bony disease* NOTE: *Elevated prostate-specific antigen (PSA) allowed

  • Meets one of the following criteria:

  • Currently on treatment with androgen-ablation therapy in the adjuvant setting

  • Rising PSA without other evidence of recurrent disease with planned treatment for at least 6 months

  • No known osteoporosis or prior osteoporotic fracture

  • Osteoporosis defined as bone density at the hip or spine of more than 2.5 standard deviations below the mean for young men

PATIENT CHARACTERISTICS:

Age

  • 18 and over

Performance status

  • Not specified

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • SGOT or SGPT no greater than 1.5 times upper limit of normal (ULN)

  • Alkaline phosphatase normal OR no greater than 1.5 times ULN with a normal bone scan

Renal

  • Creatinine no greater than 1.5 times ULN

  • No prior symptomatic hypercalcemia or hypocalcemia

Cardiovascular

  • No active heart disease

  • No congestive heart failure under active treatment

  • No myocardial infarction within the past 5 years

  • No coronary artery disease (CAD) with recent myocardial infarction

  • Patients with a remote history of CAD who are only on medical treatment (e.g., antilipid agents) are allowed

  • No prior thrombosis (deep vein thrombosis, stroke, or pulmonary embolism) or other known hypercoagulable state other than cancer

Other

  • Fertile patients must use effective contraception

  • Triglycerides no greater than 250 mg/dL (treatment allowed)

  • Able to complete questionnaire(s) by self or with assistance

  • Able to swallow pills

  • No prior hyperlipidemia (e.g., prior familial hyperlipidemia or fasting triglyceride greater than 250 mg/dL within the past 6 months)

  • No sarcoidosis

  • No parathyroid dysfunction

  • No intolerance to bisphosphonates

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • Not specified

Chemotherapy

  • No concurrent chemotherapy

Endocrine therapy

  • See Disease Characteristics

  • No concurrent systemic steroids

Radiotherapy

  • No concurrent radiotherapy

Surgery

  • More than 3 months since prior and no concurrent dental extraction, root canal, or dental implantation

Other

  • No prior bisphosphonates

  • More than 5 years since prior percutaneous transluminal coronary angioplasty

Contacts and Locations

Locations

Site City State Country Postal Code
1 CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona United States 85259
2 Mayo Clinic - Jacksonville Jacksonville Florida United States 32224-9980
3 Rush-Copley Cancer Care Center Aurora Illinois United States 60507
4 St. Joseph Medical Center Bloomington Illinois United States 61701
5 Graham Hospital Canton Illinois United States 61520
6 Memorial Hospital Carthage Illinois United States 62321
7 Eureka Hospital Eureka Illinois United States 61530
8 Galesburg Clinic Galesburg Illinois United States 61401
9 Galesburg Cottage Hospital Galesburg Illinois United States 61401
10 InterCommunity Cancer Center of Western Illinois Galesburg Illinois United States 61401
11 Mason District Hospital Havana Illinois United States 62644
12 Hopedale Medical Complex Hopedale Illinois United States 61747
13 Joliet Oncology Hematology Associates, Limited - West Joliet Illinois United States 60435
14 Kewanee Hospital Kewanee Illinois United States 61443
15 McDonough District Hospital Macomb Illinois United States 61455
16 BroMenn Regional Medical Center Normal Illinois United States 61761
17 Community Cancer Center Normal Illinois United States 61761
18 Community Hospital of Ottawa Ottawa Illinois United States 61350
19 Oncology Hematology Associates of Central Illinois - Ottawa Ottawa Illinois United States 61350
20 Cancer Treatment Center at Pekin Hospital Pekin Illinois United States 61554
21 Methodist Medical Center of Illinois Peoria Illinois United States 61603
22 Proctor Hospital Peoria Illinois United States 61614
23 CCOP - Illinois Oncology Research Association Peoria Illinois United States 61615
24 Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois United States 61615
25 OSF St. Francis Medical Center Peoria Illinois United States 61637
26 Illinois Valley Community Hospital Peru Illinois United States 61354
27 Perry Memorial Hospital Princeton Illinois United States 61356
28 St. Margaret's Hospital Spring Valley Illinois United States 61362
29 Valley Cancer Center Spring Valley Illinois United States 61362
30 Carle Cancer Center at Carle Foundation Hospital Urbana Illinois United States 61801
31 CCOP - Carle Cancer Center Urbana Illinois United States 61801
32 Saint Anthony Memorial Health Centers Michigan City Indiana United States 46360
33 McFarland Clinic, P.C. Ames Iowa United States 50010
34 Saint Anthony Regional Hospital Carroll Iowa United States 51401
35 Alegent Health Mercy Hospital Council Bluffs Iowa United States 51503
36 Mercy Capitol Hospital Des Moines Iowa United States 50307
37 CCOP - Iowa Oncology Research Association Des Moines Iowa United States 50309
38 John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines Iowa United States 50309
39 Medical Oncology and Hematology Associates at John Stoddard Cancer Center Des Moines Iowa United States 50309
40 Medical Oncology and Hematology Associates at Mercy Cancer Center Des Moines Iowa United States 50314
41 Mercy Cancer Center at Mercy Medical Center - Des Moines Des Moines Iowa United States 50314
42 John Stoddard Cancer Center at Iowa Lutheran Hospital Des Moines Iowa United States 50316
43 Mercy Cancer Center at Mercy Medical Center - North Iowa Mason City Iowa United States 50401
44 Alegent Health Community Memorial Hospital Missouri Valley Iowa United States 51555
45 Burgess Health Center Onawa Iowa United States 51040
46 Cancer Center at Ottumwa Regional Health Center Ottumwa Iowa United States 52501
47 Siouxland Regional Cancer Center Sioux City Iowa United States 51101-1733
48 Siouxland Hematology-Oncology Associates Sioux City Iowa United States 51101
49 Mercy Medical Center - Sioux City Sioux City Iowa United States 51104
50 St. Luke's Regional Medical Center Sioux City Iowa United States 51104
51 Medical Oncology and Hematology Associates - West Des Moines West Des Moines Iowa United States 50266
52 Cancer Center of Kansas - Chanute Chanute Kansas United States 66720
53 Cancer Center of Kansas - Dodge City Dodge City Kansas United States 67801
54 Cancer Center of Kansas, P.A. - El Dorado El Dorado Kansas United States 67042
55 Cancer Center of Kansas - Kingman Kingman Kansas United States 67068
56 Southwest Medical Center Liberal Kansas United States 67901
57 Cancer Center of Kansas - Newton Newton Kansas United States 67114
58 Cancer Center of Kansas, P.A. - Parsons Parsons Kansas United States 67357
59 Pratt Cancer Center of Kansas Pratt Kansas United States 67124
60 Cancer Center of Kansas - Salina Salina Kansas United States 67042
61 Cancer Center of Kansas - Wellington Wellington Kansas United States 67152
62 Associates in Womens Health Wichita Kansas United States 67203
63 Cancer Center of Kansas, P.A. Wichita Kansas United States 67208
64 Cancer Center of Kansas, P.A. - Wichita Wichita Kansas United States 67214
65 CCOP - Wichita Wichita Kansas United States 67214
66 Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas United States 67214
67 Cancer Center of Kansas - Winfield Winfield Kansas United States 67156
68 Brainerd Medical Center Brainerd Minnesota United States 56401
69 Fairview Ridges Hospital Burnsville Minnesota United States 55337
70 Mercy Hospital Coon Rapids Minnesota United States 55433
71 CCOP - Duluth Duluth Minnesota United States 55805
72 Miller-Dwan Medical Center Duluth Minnesota United States 55805
73 St. Mary's - Duluth Clinic Cancer Center Duluth Minnesota United States 55805
74 Fairview Southdale Hospital Edina Minnesota United States 55435
75 Mercy and Unity Cancer Center at Mercy and Unity Hospitals Fridley Minnesota United States 55432
76 Virginia Piper Cancer Institute at Abbott-Northwestern Hospital Minneapolis Minnesota United States 55403
77 Hubert H. Humphrey Cancer Center at North Memorial Medical Center Robbinsdale Minnesota United States 55422
78 Mayo Clinic Cancer Center Rochester Minnesota United States 55905
79 CCOP - Metro-Minnesota Saint Louis Park Minnesota United States 55416
80 CentraCare Clinic - River Campus St. Cloud Minnesota United States 56303
81 Park Nicollet Clinic St. Louis Park Minnesota United States 55416
82 United Hospital St. Paul Minnesota United States 55102
83 Ridgeview Medical Center Waconia Minnesota United States 55387
84 Rice Memorial Hospital Willmar Minnesota United States 56201
85 CCOP - Montana Cancer Consortium Billings Montana United States 59101
86 Great Falls Clinic Great Falls Montana United States 59405
87 Sletten Regional Cancer Institute Great Falls Montana United States 59405
88 Fremont Area Medical Center Fremont Nebraska United States 68025
89 Bryan LGH Medical Center West Lincoln Nebraska United States 68502
90 Cancer Resource Center - Lincoln Lincoln Nebraska United States 68510
91 St. Elizabeth Regional Medical Center Lincoln Nebraska United States 68510
92 CCOP - Missouri Valley Cancer Consortium Omaha Nebraska United States 68106
93 Immanuel Medical Center Omaha Nebraska United States 68122
94 Bergan Mercy Medical Center Omaha Nebraska United States 68124
95 Cancer Center at Creighton University Medical Center Omaha Nebraska United States 68131
96 Midlands Cancer Center at Midlands Community Hospital Papillion Nebraska United States 68046
97 Rutherford Hospital Rutherfordton North Carolina United States 28139
98 Bismarck Cancer Center Bismarck North Dakota United States 58501
99 Medcenter One Health System Bismarck North Dakota United States 58501
100 Mid Dakota Clinic, P.C. Bismarck North Dakota United States 58501
101 St. Alexius Medical Center Bismarck North Dakota United States 58501
102 Altru Cancer Center at Altru Hospital Grand Forks North Dakota United States 58201
103 Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma United States 74136
104 Geisinger Medical Center Danville Pennsylvania United States 17822-2001
105 Geisinger Medical Group State College Pennsylvania United States 16801
106 Geisinger Wyoming Valley Medical Center Wilkes-Barre Pennsylvania United States 18711
107 Rose Ramer Cancer Clinic at Anderson Area Medical Center Anderson South Carolina United States 29621
108 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina United States 29303
109 CCOP - Upstate Carolina Spartanburg South Carolina United States 29304
110 Sioux Valley Hospital and University of South Dakota Medical Center Sioux Falls South Dakota United States 57104
111 Avera McKennan Hospital and University Health Center Sioux Falls South Dakota United States 57105
112 Medical X-Ray Center Sioux Falls South Dakota United States 57105
113 Pasqua Hospital Regina Saskatchewan Canada S4T 1A5
114 Allan Blair Cancer Centre at Pasqua Hospital Regina Saskatchewan Canada S4T 7T1

Sponsors and Collaborators

  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Charles L. Loprinzi, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT00043069
Other Study ID Numbers:
  • NCCTG-N01C8
  • NCI-2012-02482
  • NCI-P02-0229
  • CDR0000069502
First Posted:
Jan 27, 2003
Last Update Posted:
Dec 7, 2016
Last Verified:
Dec 1, 2016

Study Results

No Results Posted as of Dec 7, 2016